Congestive Heart Failure Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure
Condition: Congestive Heart Failure Interventions: Drug: OPC-61815; Drug: Tolvaptan Tab 15 MG Sponsor: Otsuka Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2018 Category: Research Source Type: clinical trials